SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (25821)9/29/1998 1:36:00 PM
From: Robert Cohen  Read Replies (1) | Respond to of 32384
 
SAN DIEGO, Calif. and DUBLIN, Ireland--(BW HealthWire)--Sept. 29, 1998--Ligand Pharmaceuticals Incorporated LGND and Elan Corp., plc ELN announced today the signing of a binding letter of agreement under the terms of which Elan will (i) purchase $20.0 million of Ligand Common Stock; (ii) purchase from Ligand up to $110 million in issue price of Zero Coupon Convertible Senior Notes due 2008 with an 8.0% per annum yield to maturity

Robert



To: Henry Niman who wrote (25821)9/29/1998 1:36:00 PM
From: Brian Moore  Read Replies (1) | Respond to of 32384
 
LGND's price is again on the move as it falls 15/16 to 11 7/16.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News